Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2020
Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterialsMoataz Reda, Alexander F Bagley, Husam Y Zaidan, et al.
International Journal of Nanomedicine|July 20, 2018
Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA deliveryWorapol Ngamcherdtrakul, Thanapon Sangvanich, Moataz Reda, et al.
Plos One|June 8, 2018
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatmentShenda Gu, Worapol Ngamcherdtrakul, Moataz Reda, et al.
Scientific Reports|January 26, 2019
Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent modelWorapol Ngamcherdtrakul, Jingga Morry, Thanapon Sangvanich, et al.
Cancer Treatment Reviews|March 2, 2016
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatmentWorapol Ngamcherdtrakul, David J Castro, Shenda Gu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 21, 2023
Nanotechnology Applications in Breast Cancer ImmunotherapyRuijie Wang, Pramod Kumar, Moataz Reda, et al.
Cancer Letters|September 30, 2019
PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancerMoataz Reda, Worapol Ngamcherdtrakul, Shenda Gu, et al.
Bioengineering (Basel, Switzerland)|March 17, 2019
Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein AnalysisWorapol Ngamcherdtrakul, Thanapon Sangvanich, Shaun Goodyear, et al.
Molecular Cancer Therapeutics|February 1, 2017
Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle PlatformJingga Morry, Worapol Ngamcherdtrakul, Shenda Gu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2026
High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor MicroenvironmentRuijie Wang, Pramod Kumar, Noah A Crumrine, et al.
Pageof 2